These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35731167)

  • 1. Cytisine induced urticaria : a case report during a smoking cessation treatment.
    Campagnari S; Casari R; Zamboni L; Fusina F; Lugoboni F
    Acta Biomed; 2022 Jun; 93(S1):e2022073. PubMed ID: 35731167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness, safety and cost-effectiveness of cytisine versus varenicline for smoking cessation in an Australian population: a study protocol for a randomized controlled non-inferiority trial.
    Thomas D; Farrell M; McRobbie H; Tutka P; Petrie D; West R; Siahpush M; Gartner C; Walker N; Mendelsohn CP; Hall W; Paul C; Zwar N; Ferguson SG; Boland VC; Richmond R; Doran CM; Shakeshaft A; Mattick RP; Courtney RJ
    Addiction; 2019 May; 114(5):923-933. PubMed ID: 30589984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial.
    Courtney RJ; McRobbie H; Tutka P; Weaver NA; Petrie D; Mendelsohn CP; Shakeshaft A; Talukder S; Macdonald C; Thomas D; Kwan BCH; Walker N; Gartner C; Mattick RP; Paul C; Ferguson SG; Zwar NA; Richmond RL; Doran CM; Boland VC; Hall W; West R; Farrell M
    JAMA; 2021 Jul; 326(1):56-64. PubMed ID: 34228066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomized non-inferiority trial.
    Walker N; Smith B; Barnes J; Verbiest M; Kurdziel T; Parag V; Pokhrel S; Bullen C
    Addiction; 2019 Feb; 114(2):344-352. PubMed ID: 30276931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation.
    Leaviss J; Sullivan W; Ren S; Everson-Hock E; Stevenson M; Stevens JW; Strong M; Cantrell A
    Health Technol Assess; 2014 May; 18(33):1-120. PubMed ID: 24831822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytisine versus varenicline for smoking cessation in New Zealand indigenous Māori: a randomized controlled trial.
    Walker N; Smith B; Barnes J; Verbiest M; Parag V; Pokhrel S; Wharakura MK; Lees T; Cubillos Gutierrez H; Jones B; Bullen C
    Addiction; 2021 Oct; 116(10):2847-2858. PubMed ID: 33761149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006103. PubMed ID: 17253581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytisine for nicotine addiction treatment: a review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation.
    Tutka P; Vinnikov D; Courtney RJ; Benowitz NL
    Addiction; 2019 Nov; 114(11):1951-1969. PubMed ID: 31240783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytisine as a smoking cessation aid: Preliminary observations with a modified therapeutic scheme in real life.
    Pozzi P; Boffi R; Veronese C; Trussardo S; Valsecchi C; Sabia F; Pastorino U; Apolone G; Cardani E; Tarantini F; Munarini E
    Tumori; 2024 Apr; 110(2):124-131. PubMed ID: 38149659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public Health Impact of FDA's Request for Additional Safety Data on Cytisine for Tobacco Cessation.
    Reddy KP; Paltiel AD; Freedberg KA; Rigotti NA
    JAMA Health Forum; 2024 Aug; 5(8):e242647. PubMed ID: 39177985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
    Dogar O; Keding A; Gabe R; Marshall AM; Huque R; Barua D; Fatima R; Khan A; Zahid R; Mansoor S; Kotz D; Boeckmann M; Elsey H; Kralikova E; Parrott S; Li J; Readshaw A; Sheikh A; Siddiqi K;
    Lancet Glob Health; 2020 Nov; 8(11):e1408-e1417. PubMed ID: 33069301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental health related adverse events of cytisine and varenicline in smokers with and without mental health disorders: Secondary analysis of a randomized controlled trial.
    Rubaiya Talukder S; Lappin J; Clare Boland V; Weaver N; McRobbie H; James Courtney R
    Addict Behav; 2024 Dec; 159():108148. PubMed ID: 39213816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Cytisine vs Varenicline on Smoking Cessation.
    Lang AE
    JAMA; 2021 Nov; 326(18):1872. PubMed ID: 34751716
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytisine versus nicotine for smoking cessation.
    Walker N; Howe C; Glover M; McRobbie H; Barnes J; Nosa V; Parag V; Bassett B; Bullen C
    N Engl J Med; 2014 Dec; 371(25):2353-62. PubMed ID: 25517706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytisine for smoking cessation: a research agenda.
    Etter JF; Lukas RJ; Benowitz NL; West R; Dresler CM
    Drug Alcohol Depend; 2008 Jan; 92(1-3):3-8. PubMed ID: 17825502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of CyTisine for smoking cessation in a hOSPital context (CITOSP): study protocol for a prospective observational study.
    Torazzi A; Tedesco E; Ceccato S; Santin L; Campagnari S; Losso L; Toldo S; Casari R; Arzenton E; Marini P; Chiamulera C; Lugoboni F
    Front Public Health; 2024; 12():1350176. PubMed ID: 39403432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.